Pj. Mills et al., THE EFFECTS OF THE MENSTRUAL-CYCLE, RACE, AND GENDER ON ADRENERGIC-RECEPTORS AND AGONISTS, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 99-104
Objective: To examine possible effects of race, sex, and the menstrual
cycle on adrenergic receptors (beta(2) and alpha(2)) and agonists. Me
thods: Sixty-three normotensive black men and women and white men and
women were studied twice, approximately 6 weeks apart. Women were stud
ied once during the follicular phase and once during the luteal phase
of the menstrual cycle. beta(2)-Adrenergic receptors and adenylate cyc
lase activity were examined on lymphocytes, and alpha(2)-adrenergic re
ceptors were examined on platelets, Norepinephrine and epinephrine wer
e determined in plasma, Results: Women showed greater lymphocyte beta(
2)-receptor sensitivity (isoproterenol-stimulated cyclic adenosine mon
ophosphate; p = 0.009). Women also showed greater postreceptor adenyla
te cycle activity independent of the beta-receptor (forskolin stimulat
ion; p = 0.006). When these differences were controlled for, the gende
r-related differences in beta(2)-receptor sensitivity were no longer e
vident, Black women had a reduced beta(2)-receptor sensitivity in the
luteal phase compared with the follicular phase, whereas white women s
howed no significant change (p = 0.018). Black subjects had lower lymp
hocyte beta(2)-receptor density (B-max) values than white subjects (p
= 0.047). There were no significant effects on alpha(2)-adrenergic rec
eptors. Conclusion: The findings suggest that although there is no gen
eralized effect of the menstrual cycle on adrenergic receptors in whit
e women, such an effect may occur in black women. The findings also su
ggest that previously reported gender-related differences in beta(2)-r
eceptor sensitivity may be due to gender-related differences in postre
ceptor activity and not the beta(2)-receptor per se.